Virus du papillome humain

Why Public Schools Should Require the HPV Vaccine

If you live in Rhode Island and your children go to public school, they will need to be vaccinated against the Human Papilloma Virus, or HPV. This is a new requirement—and not everyone likes it. Those who oppose the change point out that you catch HPV through sex, unlike infections like measles or whooping cough that you can catch if someone in the classroom has it and coughs on you. Why, they say, should the HPV vaccine be required for school?
Because it could save lives, that’s why.

EU Drug Regulator Starts Safety Review of HPV Vaccines

The European Medicines Agency says it has started a review of cervical cancer vaccines to see if they are linked to two rare conditions, but emphasized it hasn't changed its recommendations for how the shots should be used.
The vaccines against HPV have been used in more than 70 million people worldwide and prevent cancers caused by HPV, including those of the cervix and womb.

ACOG Updates Recommendations to Include 9-Valent HPV Vaccine

A key role of obstetrician/gynecologists and other healthcare providers is to provide patients and their parents with information on the benefits and safety of the human papillomavirus (HPV) vaccine and to encourage adolescents to receive the HPV immunization, according to updated recommendations published online June 26 by the American College of Obstetricians and Gynecologists.

Cervical cancer vaccine might work after just 1 shot, not 3

Following outbreaks of vaccine-preventable diseases in the United States in the last couple of years, the American Medical Association approved a policy to seek tighter limits on non-medical exemptions to vaccinations.
The policy specifically recommends that states establish a method to involve "qualified public health physicians" to determine the vaccines required for admission to schools, as well as that physicians and public health officials be obligated to accept immunization in the absence of an accepted medical reason.

HPV vaccinations increase with electronic health record prompts

A recent study found that patients whose electronic health records sent out reminders about the HPV vaccine were more likely to receive the full dosage of the vaccine to prevent cervical cancer.
Researchers at the University of Michigan found that young adults ages of 9 to 18 were three times more likely to begin receiving HPV vaccinations and 10 times more likely to finish the doses of HPV vaccinations if they received reminders from their health providers. The reminders were sent electronically when the patient was due for a vaccine.

La semaine mondiale de la vaccination a pour objectif de « combler les lacunes en matière de vaccination » et de présenter « un cadeau pour la vie » en Afrique

La Semaine mondiale de la vaccination (SMV) de l'Organisation mondiale de la Santé, qui se déroule cette année du 24 au 30 avril, vise à sensibiliser la population à l'importance de la vaccination pour les personnes de tous âges et à augmenter les taux de vaccination contre les maladies pouvant être évitées par la vaccination dans le monde entier. Cette année, la SMV est dédiée à « combler les lacunes en matière de vaccination ». La Semaine africaine de la vaccination est célébrée sous le slogan « La vaccination, un cadeau pour la vie ».

China Human Vaccine Industry Report, 2015-2018

A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to suspected deaths stemming from vaccination and some companies' (such as Shenzhen Kangtai, Tiantan Biological and Dalian Hissen) production halts of some products because of their failure to pass new GMP certification, China's human vaccine lot release volume in 2014 declined by 2.4% year on year to 791 million doses.

La confiance des médecins dans la vaccination, point clef pour l'application des recommandations vaccinales

Ces dernières années, un accroissement préoccupant d'opinions défavorables à la vaccination a été constaté dans la population générale en France. Plusieurs controverses ont eu lieu depuis la fin des années 1990 :
  • maladies neurodégénératives et vaccination contre l'hépatite B,
  • remise en cause de la vaccination contre la grippe pandémique A(H1N1)pdm09,
  • plaintes pénales à propos d'événements indésirables attribués à la vaccination contre les papillomavirus,
  • mise en cause de l'aluminium présent dans certains vaccins.

Sanofi, Merck win EMA nod for Gardasil 9

Merck's ($MRK) new-and-improved Gardasil is making headway in Europe with the word late last week that the European Medicines Agency (EMA) has recommended the jab against 9 types of human papillomavirus (HPV) and will send its blessing to the European Commission.

European committee gives positive review to GARDASIL 9 HPV vaccine

The European Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMA), recently gave positive reviews of the new HPV vaccine, GARDASIL 9.
The new nine-valent HPV vaccine, developed by Sanofi Pasteur MSD, now has the EMA’s recommendation to be authorized for administration to males and females as young as 9 years old. The vaccine is meant to protect people from cervix, vaginal, vulva and anus cancers, in addition to premalignant lesions, genital warts and other HPV symptoms.